Investors
Events & presentations
Financial information
Financial reports & calendar
External financial reports
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
2024-02-23 – Bokslutskommuniké 2024
2024-05-02 – Årsredovisning 2023
2024-05-02 – Årsredovisning 2023 – Revisionsberättelse
2024-05-03 – Årsstämma
2024-05-03 – Delårsrapport Q1 2024 (januari-mars)
2024-08-16 – Halvårsrapport H1 2023 (januari-juni)
2024-08-16 – Delårsrapport Q2 2023 (april-juni)
2024-11-22 – Delårsrapport Q3 2023 (juli-september)
2023-02-24 – Bokslutskommuniké 2022
2023-05-04 – Årsredovisning 2022
2023-05-04 – Årsredovisning 2022 – Revisionsberättelse
2023-05-05 – Delårsrapport Q1 2023 (jan-mar)
2023-08-18 – Halvårsrapport H1 2023 (januari-juni)
2023-08-18 – Delårsrapport Q2 2023 (april-juni)
2023-11-24 – Delårsrapport Q3 2023 (juli-september)
2022-02-25 – Bokslutskommuniké 2021
2022-04-08 – Årsredovisning 2021
2022-04-08 – Årsredovisning 2021 – Revisionsberättelse
2022-05-06 – Delårsrapport Q1 2022 (jan-mar)
2022-08-19 – Halvårsrapport H1 2022 (jan-jun)
2021-02-25 – Bokslutskommuniké 2020
2021-05-07 – Årsredovisning 2020
2021-05-07 – Delårsrapport Q1 2021 (jan-mar)
2020-11-27 – Delårsrapport Q3 2020 (jul-sep)
2020-08-18 – Halvårsrapport H1 2020 (jan-jun)
2020-05-08 – Årsredovisning 2019
2019-11-29 – Delårsrapport Q3 2019 (juli-sep)
2019-08-20 – Halvårsrapport H1 2019 (jan-jun)
2019-05-07 – Delårsrapport Q1 2019 (jan-mar)
2019-03-22 – Årsredovisning 2018
2019-02-25 – Bokslutskommuniké 2018
Årsredovisning – 2017-01-01 - 2017-12-31
Årsredovisning – 2016-07-01 - 2016-12-31
Årsredovisning – 2015-07-01 - 2016-06-30
- 2022
- 2021
- 2020
- 2019
Memorandums & offerings
- 2022
- 2020
- 2019
- 2018
- 2017
2022-12-08 – Så här gör du för att teckna aktier i Attana
2018-03-07 – Första handelsdag på NGM
Stock information
Attana has issued shares in one class. You can follow the development here.
The share capital in the company is SEK 1,254,414 divided into 209,067,428 shares with a quota value of SEK 0.006.
Name: ATANA
ISIN: SE0010547273
Investor relations
Marcus Söderberg – CEO
Tel: +46-8-410 200 00
Email: ir@attana.com
News & press
Attana’s press announcements and news are published via Cision. Attana communicates in Swedish or English. Attana AB is required under the Swedish Securities Market Act to disclose certain information and such information is primarily provided in Swedish on the Swedish news room.
Information related to scientific publications from the company’s customers is primarily provided in English on the English news room.
If you wish to receive all information from Attana we recommend that you subscribe for news written in Swedish and English by visiting the news rooms.
Corporate governance
General meetings
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
2022-11-23 – Styrelsens redogörelse över väsentliga händelser
2022-11-23 – Revisorns yttrande över styrelsens redogörelse
2022-11-09 – Kallelse till bolagstämma
2022-11-09 – Fullmakt (bolagsstämma)
2020-10-26 – Styrelsens redogörelse över väsentliga händelser (9 november)
2020-10-26 – Revisorns yttrande över styrelsens redogörelse (9 november)
2020-10-26 – Fullständiga förslag till emissionen (9 november)
2020-10-21 – Kallelse till extra bolagsstämma (9 november)
2020-10-21 – Notice to attend extraordinary general meeting (November 9)
2020-05-08 – Årsstämma verksamhetsår 2019
Other company documents
- Bolagsordning
- Registreringsbevis
Board of Directors
Lena Jendeberg (b. 1964)
Director since 2018
PhD from KTH Royal Institute of Technology with 25+ years of experience in the pharmaceutical industry working at Pharmacia, Biovitrum, Sobi, Modus Therapeutics and Wilson Therapeutics. Have developed pharmaceuticals all the way from the pre-clinical phase to improvement of approved products.